Fundraising Fox

HelloSelf

Founded 2018 · 76 employees on LinkedIn · 5 known investors

HelloSelf creates a platform that connects therapists and members to facilitate mental healthcare relationships. The company partners with healthcare providers to improve access to mental health services.

Also known as HelloSelf

Founders & leadership

HelloSelf was founded in 2018 by Charlie Wells.

CW
Charlie WellsFounder & CEO

Investors · 5

Also in the syndicate · 1

Oxford Capital

Company profile

researched Aug 2026

HelloSelf operates an online mental health platform that matches members with therapists, clinical psychologists and coaches, and delivers sessions through its own secure video platform and app. Services span adult therapy, teen therapy, neurodiversity coaching and other specialist areas, with the company stating its network covers more than 150 conditions and treatments. Therapists are assessed and supervised by an in-house clinical team.

The member journey begins with an online sign-up questionnaire, after which a dedicated matching team proposes clinicians for the member to choose from. Alongside live sessions, the platform provides worksheets and session notes, one-to-one chat with the therapist for activities and reminders, and wellness tracking tools for setting goals, tracking emotions and measuring outcomes before, during and after care. The company has also introduced "Companion", an AI feature created by clinicians and briefed by the member's therapist, which summarises sessions, highlights takeaways and next steps, supports check-ins between sessions and helps measure progress; a post-therapy subscription extends Companion access under therapist oversight.

The company describes itself as a team of psychologists, technologists, developers and creatives, and positions its mission as improving access to effective mental healthcare in partnership with healthcare providers. Press coverage characterises HelloSelf as a telehealth and self-guided mental health services company that connects providers and patients rather than directly employing and controlling clinicians.

Founding story

Founder and CEO Charlie (Charles) Wells has described a near-death experience — surviving a category five brain haemorrhage and undergoing extensive neuro-rehabilitation — as the impetus for entering the brain technology and mental health space, after a career spanning marketing, charity work, angel investing and entrepreneurship. He has framed HelloSelf around personalised psychological support and therapy that helps people become their own therapists.

Business model

HelloSelf provides therapy sessions delivered by a network of therapists and coaches through its own platform, combining live clinical sessions with digital tools and an AI companion product. It works with healthcare providers and insurers as payment and distribution channels, and offers a post-therapy subscription for continued support.

Sessions are paid for privately or through private medical insurance. Publicly listed private rates are £130 per session with a clinical psychologist and £115 per session with a CBT therapist. The company also offers a paid post-therapy subscription giving continued access to its Companion product with therapist oversight.

Traction

The company reports coverage by major insurers, a growing network of therapists and coaches spanning 150+ conditions and treatments, a published library of over 130 advice articles, and member reviews on Trustpilot. It secured an NHS pilot program in 2022 and had raised $11.3 million before its $20 million Series B in March 2023.

Latest developments

HelloSelf markets Companion, an AI feature briefed by a member's therapist that summarises sessions, supports between-session check-ins and measures progress, together with a post-therapy subscription that extends Companion access under therapist oversight. In October 2024 founder and CEO Charles Wells discussed the company's approach to neurotechnology and AI on the Riding Unicorns podcast.

Full profile — market position, technology, go-to-market, geography, history

Market position

Positioned in the virtual mental health category alongside other platforms connecting patients with providers; coverage of its 2023 Series B noted comparable investor interest in peers such as Headway in the United States.

The company emphasises human matching by a dedicated team rather than self-serve selection, in-house clinical governance and supervision of its therapist network, and continuity of support before, during and after treatment via its app and AI Companion. It cites internal findings that members engaging with its app and platform notice improvement 40% faster and that entering therapy with clarity brings improvement in the first session versus an average of 1.8 sessions.

Technology

A secure online therapy platform and mobile app supporting video sessions, worksheets and session notes, confidential one-to-one chat, goal setting, emotion tracking and outcome measurement. The Companion feature applies AI, briefed by the member's therapist, to summarise sessions, surface key takeaways and next steps, prompt between-session check-ins and track progress.

Go-to-market

Direct-to-consumer sign-up through the company website with a guided matching process, supported by a content and advice library on mental health topics, alongside insurer coverage arrangements with providers such as BUPA, AXA, Vitality, Cigna and Aviva, and partnerships with healthcare providers including a 2022 pilot with the UK's National Health Service.

Adults and teenagers seeking therapy or coaching, including people with anxiety, depression, ADHD, trauma, grief, relationship and other presentations; also insurers and healthcare providers that fund or refer members.

Geography

Headquartered in London, United Kingdom, serving members in the UK with insurer coverage from UK providers including BUPA, AXA, Vitality, Cigna and Aviva.

History

The company built an online therapy platform in London, secured a pilot with the UK National Health Service in 2022, and raised a $20 million Series B led by Octopus Ventures in March 2023, having previously raised $11.3 million. It has since added the AI-based Companion product and a post-therapy subscription tier.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Conditions and treatments coveredJan 2025150+
HeadcountAug 202676
Reported speed of improvement for members engaging with the app and platformJan 2025Notice improvement 40% faster
Session price, CBT therapistJan 2025115 GBP per session
Session price, clinical psychologistJan 2025130 GBP per session
Total funding raised prior to Series BMar 2023$11.3M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 5

by search overlap

Companies competing with HelloSelf for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 2

launches, deals, and filings
Mar 2023
HelloSelf announces $20M Series B led by Octopus Ventures

HelloSelf secured a $20 million funding round led by Octopus Ventures, joined by OMERS Ventures, Manta Ray Ventures and Oxford Capital. Prior to the round the company had raised $11.3 million.

$20M source ↗

Jan 2022
Pilot program with the UK National Health Service

In 2022 HelloSelf secured a pilot program with the United Kingdom's National Health Service.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does HelloSelf do?
HelloSelf is a London-based digital mental health platform matching members with therapists and coaches for online therapy.
Who founded HelloSelf?
HelloSelf was founded by Charlie Wells in 2018.
Who are HelloSelf's investors?
HelloSelf's investors include Manta Ray Ventures, Octopus Ventures, OMERS Ventures, Oxford.